United States · Bill · S
S. 1056 (110th)
National Cancer Act of 2007
Introduced
29 March 2007
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
10 February 2026
Summary
National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research. Provides for research on cancer treatments that target cancer cells, the cancer care workforce, cancer survivorship, environmental risk factors for cancer, and treatment disparities. Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out demonstration programs on: (1) lung cancer early detection using Computer Tomography (CT) scanning; and (2) colorectal screening. Amends the Federal Food, Drug, and Cosmetic Act to set forth provisions for chemoprevention drugs that: (1) allow the Secretary to designate such drugs; and (2) provide market exclusivity for seven years for approved drugs or licensed biological products. Defines "chemoprevention drug" as a drug designed to treat a high-risk medical condition that: (1) has been diagnosed in individuals who have not been diagnosed with cancer or who do not currently have progressive, life-threatening cancer; and (2) unless treated, could develop into progressive and life-threatening cancer. Establishes the ChemoPrevention Products Board to develop chemoprevention drugs and devices. Requires the Secretary to establish a program to expand access to investigational treatments for individuals diagnosed with cancer. Amends title XVIII (Medicare) of the Social Security Act to provide coverage for cancer care coordinators who provide overall coordination and management of the medical, nursing, and other health services provided to individuals diagnosed with cancer. Allows a biorepository to adopt specified guidelines for the collection of biospecimens. Requires the Medicare Payment Assessment Commission (MedPAC) to report to Congress on developing a payment system for collecting and storing cancer tissue for research.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 29 March 2007
Introduced in Senate (PDF)
Introduced in Senate · EN · 29 March 2007
Introduced in Senate
summary · EN · 29 March 2007
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/110th-congress/senate-bill/1056
- Open data entity: https://api.congress.gov/v3/bill/110/s/1056